Rochester Clinical Site - Site 12 — Rochester, New York

Rochester Clinical Site - Site 12 is a clinical research site located in Rochester, New York, United States.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Rochester Clinical Site - Site 12 has participated in 1 clinical trials.

Therapeutic areas: Glaucoma, Ocular Hypertension, Eye Disease.

Sponsors: Amakem, NV.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester Clinical Site - Site 12?

Rochester Clinical Site - Site 12 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester Clinical Site - Site 12 conducted?

Rochester Clinical Site - Site 12 has 1 clinical trials on record. Their work covers Glaucoma, Ocular Hypertension, Eye Disease.

Is Rochester Clinical Site - Site 12 accredited by Crixeo Health?

Rochester Clinical Site - Site 12 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester Clinical Site - Site 12?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.